Free Trial
NASDAQ:GUTS

Fractyl Health (GUTS) Stock Price, News & Analysis

Fractyl Health logo
$0.99 +0.02 (+1.61%)
Closing price 09/18/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+1.21%)
As of 08:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fractyl Health Stock (NASDAQ:GUTS)

Advanced

Key Stats

Today's Range
$0.97
$1.01
50-Day Range
$0.90
$1.97
52-Week Range
$0.83
$3.48
Volume
695,623 shs
Average Volume
758,678 shs
Market Capitalization
$49.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.15
Consensus Rating
Buy

Company Overview

Fractyl Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

GUTS MarketRank™: 

Fractyl Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 479th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fractyl Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    Fractyl Health has a consensus price target of $7.15, representing about 623.7% upside from its current price of $0.99.

  • Amount of Analyst Coverage

    Fractyl Health has only been the subject of 3 research reports in the past 90 days.

  • Read more about Fractyl Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Fractyl Health are expected to decrease in the coming year, from ($1.61) to ($1.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fractyl Health is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fractyl Health is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Fractyl Health has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Fractyl Health's valuation and earnings.
  • Percentage of Shares Shorted

    6.88% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fractyl Health has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Fractyl Health does not currently pay a dividend.

  • Dividend Growth

    Fractyl Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.88% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fractyl Health has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Fractyl Health has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Fractyl Health this week, compared to 2 articles on an average week.
  • Search Interest

    11 people have searched for GUTS on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Fractyl Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Fractyl Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    26.10% of the stock of Fractyl Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Fractyl Health's insider trading history.
Receive GUTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GUTS Stock News Headlines

HC Wainwright Predicts Fractyl Health Q3 Earnings
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.tc pixel
Fractyl Health Inc News (GUTS) - Investing.com
See More Headlines

GUTS Stock Analysis - Frequently Asked Questions

Fractyl Health's stock was trading at $2.06 on January 1st, 2025. Since then, GUTS shares have decreased by 52.0% and is now trading at $0.9880.

Fractyl Health, Inc. (NASDAQ:GUTS) posted its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by $0.16. Fractyl Health had a negative net margin of 73,864.52% and a negative trailing twelve-month return on equity of 584.35%.
Read the conference call transcript
.

Fractyl Health (GUTS) raised $110 million in an IPO on Friday, February 2nd 2024. The company issued 7,333,333 shares at $15.00 per share.

Fractyl Health's top institutional investors include General Catalyst Group Management LLC (9.97%), Y Intercept Hong Kong Ltd (0.23%), Geode Capital Management LLC (0.23%) and Qube Research & Technologies Ltd (0.16%). Insiders that own company stock include Ajay Royan, Harith Rajagopalan, Jay David Caplan and William Bradley.
View institutional ownership trends
.

Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fractyl Health investors own include SoFi Technologies (SOFI), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/12/2025
Today
9/18/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GUTS
Previous Symbol
NASDAQ:GUTS
CIK
1572616
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$3.60
Potential Upside/Downside
+623.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.69 million
Net Margins
-73,864.52%
Pretax Margin
-586,864.69%
Return on Equity
-584.35%
Return on Assets
-102.88%

Debt

Debt-to-Equity Ratio
4.61
Current Ratio
1.22
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$17 thousand
Price / Sales
2,922.68
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.59 per share
Price / Book
1.67

Miscellaneous

Outstanding Shares
50,289,000
Free Float
37,164,000
Market Cap
$49.69 million
Optionable
N/A
Beta
1.55

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:GUTS) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners